[The serum and tissue concentration of FT-207, 5'-DFUR and 5-FU in patients with breast cancer by preoperative administration of UFT and 5'-DFUR].
Kosaka
A
A
Dept. of Surgery, Shimizu Municipal Hospital.
Sumiyoshi
K
K
Ando
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000493:pharmacokinetics*; D001940:Breast / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D005467:Floxuridine / Q000097:blood / Q000493:pharmacokinetics*; D005472:Fluorouracil / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D008198:Lymph Nodes / Q000378:metabolism; D011300:Preoperative Care; D005641:Tegafur / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D014018:Tissue Distribution; D014498:Uracil / Q000008:administration & dosage
D005467:Floxuridine; D005641:Tegafur; D014498:Uracil; D005472:Fluorouracil; C025034:doxifluridine